Du är här

2016-02-09

Hofseth Biocare ASA : New study shows ProGo(TM) significantly reduces BMI

Hofseth BioCare ASA's new study on the effects of HBCs salmon protein ProGo(TM) has been accepted for publication in the Journal of Obesity&Weight Loss Therapy in USA.
The article called "A Placebo-Controlled, Randomized Study on the Impact of Dietary Salmon Protein Hydrolysate Supplementation on Body Mass Index in Overweight Human Subjects", shows that a daily dietary intake of 16 g of HBCs salmon protein hydrolysate powder for 42 days, statistically significantly reduced Body Mass Index by 5.6 % in overweight subjects, in comparison with whey protein isolate as a placebo-control.
Four metabolism-relevant serum biomarkers - bile acid, interleukin-6, Preheparin lipoprotein lipase mass and adiponectin - were also positively impacted using one-tailed, paired student t-test analysis, leading to the proposed metabolism-elevating mode-of-action. Diet and exercise levels were maintained for each subject as per their normal levels.
HBC has already started further research to identify the active individual peptide components in our ProGo(TM) in terms of specific biological activity for obesity control. Salmon protein hydrolysate powder in supplemental doses may be a useful tool in the long-term management of obesity.
- Obesity is a major global health problem with over 3 million adults dying each year from obesity related complications. Overweight and obese individuals with abnormal or excessive fat accumulation are at increased risk of type-2 diabetes, cardiovascular disease and metabolic disorders, particularly cancer, says Dr. Bomi Framroze, Chief Scientific Officer at Hofseth BioCare ASA.
Read the article on HBCs website:
http://www.hofsethbiocare.com/latest/new-study-show-that-progo-significa...

ProGo(TM) powder can be purchased atwww.biocareshop.no
For further information, please contact:
Dr. Bomi Framroze, CSO of Hofseth BioCare ASA

Tel: +91 982006524
Email:bf@hofsethbiocare.no
Jon Olav Ødegård, CEO of Hofseth BioCare ASA

Tel: +47 93632966
Email:joo@hofsethbiocare.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biotech company that offers high-value ingredients and finished products for humans and pets. The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources. Through an innovative hydrolysis technology, Hofseth BioCare is able to preserve the quality of salmon oil, proteins and calcium, prepared of fresh salmon off-cuts. Hofseth BioCare`s objective is to contribute to the efficient use of marine resources and deliver quality products for ingredients and finished consumer products in the nutrition market.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hofseth Biocare ASA via Globenewswire

HUG#1984725

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.